TME-SW
01698
ALI HEALTH
00241
TENCENT
00700
MEITUAN-W
03690
KUAISHOU-W
01024
(Q6)Jun 30, 2024 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | ---- | -107.23%-2.96B | ---- | -24.27%40.98B | ---- | -11.57%54.12B | ---- | 26.08%61.2B | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | 17.12%-1.77B | ---- | 47.88%-2.14B | ---- | -73.01%-4.1B | ---- | 3.03%-2.37B | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | 26.26%-3.73B | ---- | 19.26%-5.05B | ---- | -22.51%-6.26B | ---- | -326.73%-5.11B | ---- |
Impairment and provisions: | ---- | ---- | 85.28%3.06B | ---- | 13.94%1.65B | ---- | -4.36%1.45B | ---- | 28.83%1.52B | ---- |
-Other impairments and provisions | ---- | ---- | 85.28%3.06B | ---- | 13.94%1.65B | ---- | -4.36%1.45B | ---- | 28.83%1.52B | ---- |
Revaluation surplus: | ---- | ---- | 143.41%270M | ---- | -181.45%-622M | ---- | 40.27%-221M | ---- | 78.30%-370M | ---- |
-Fair value of investment properties (increase) | ---- | ---- | -48.46%117M | ---- | 1,846.15%227M | ---- | 89.68%-13M | ---- | 92.73%-126M | ---- |
-Derivative financial instruments fair value (increase) | ---- | ---- | -192.37%-109M | ---- | -75.82%118M | ---- | 258.44%488M | ---- | -1,300.00%-308M | ---- |
-Other fair value changes | ---- | ---- | 127.09%262M | ---- | -38.94%-967M | ---- | -1,187.50%-696M | ---- | 30.61%64M | ---- |
Asset sale loss (gain): | ---- | ---- | 1,462.50%1.75B | ---- | 112.64%112M | ---- | 14.73%-886M | ---- | -115.11%-1.04B | ---- |
-Loss (gain) from sale of subsidiary company | ---- | ---- | 1,892.41%1.57B | ---- | 109.31%79M | ---- | 12.20%-849M | ---- | -112.53%-967M | ---- |
-Loss (gain) on sale of property, machinery and equipment | ---- | ---- | 433.33%176M | ---- | 189.19%33M | ---- | 48.61%-37M | ---- | -157.14%-72M | ---- |
Depreciation and amortization: | ---- | ---- | -5.07%2.27B | ---- | 15.48%2.39B | ---- | 33.53%2.07B | ---- | 48.28%1.55B | ---- |
-Amortization of intangible assets | ---- | ---- | 13.53%302M | ---- | 31.03%266M | ---- | 73.50%203M | ---- | -13.33%117M | ---- |
Exchange Loss (gain) | ---- | ---- | 596.98%8.38B | ---- | 48.00%-1.69B | ---- | -370.17%-3.24B | ---- | 22.82%1.2B | ---- |
Special items | ---- | ---- | -77.31%6.43B | ---- | -8.62%28.33B | ---- | -17.16%31B | ---- | 23.11%37.42B | ---- |
Operating profit before the change of operating capital | ---- | ---- | -78.59%13.69B | ---- | -13.48%63.96B | ---- | -21.35%73.92B | ---- | 23.19%94B | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---- | ---- | 364.74%2.41B | ---- | -40.62%519M | ---- | 129.54%874M | ---- | 35.36%-2.96B | ---- |
Developing property (increase)decrease | ---- | ---- | 88.92%260.38B | ---- | 258.55%137.83B | ---- | 10.50%-86.93B | ---- | 45.32%-97.13B | ---- |
Accounts receivable (increase)decrease | ---- | ---- | -9.79%67.58B | ---- | 107.26%74.91B | ---- | 528.70%36.14B | ---- | 105.94%5.75B | ---- |
Accounts payable increase (decrease) | ---- | ---- | -48.56%-287.16B | ---- | -1,459.05%-193.3B | ---- | -82.83%14.22B | ---- | -71.20%82.83B | ---- |
Special items for working capital changes | ---- | ---- | 197.92%17.79B | ---- | -496.25%-18.17B | ---- | 232.71%4.59B | ---- | -96.20%-3.46B | ---- |
Cash from business operations | -75.54%4.43B | -39.42%18.09B | 13.60%74.69B | -36.87%29.87B | 53.55%65.75B | 117.16%47.31B | -45.82%42.82B | -36.57%21.79B | -4.94%79.04B | 39.81%34.35B |
Other taxs | 81.25%-1.49B | 50.69%-7.95B | 40.87%-22.01B | 41.56%-16.13B | 11.71%-37.22B | -3.08%-27.6B | -2.72%-42.16B | -16.21%-26.77B | -14.97%-41.04B | -64.99%-23.04B |
Interest paid - operating | 53.81%-3.12B | 20.42%-6.75B | 3.47%-17.06B | 9.09%-8.49B | 20.72%-17.68B | 15.81%-9.33B | 4.43%-22.3B | -16.67%-11.09B | -29.12%-23.33B | -27.77%-9.5B |
Net cash from operations | -105.46%-185M | -35.54%3.39B | 228.15%35.62B | -49.39%5.25B | 150.18%10.86B | 164.58%10.38B | -247.49%-21.63B | -988.94%-16.07B | -50.08%14.67B | -42.91%1.81B |
Cash flow from investment activities | ||||||||||
Interest received - investment | -59.73%387M | 5.14%961M | -17.12%1.77B | -32.30%914M | -47.88%2.14B | -39.87%1.35B | 73.01%4.1B | 49.07%2.25B | -3.03%2.37B | 93.82%1.51B |
Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -46.67%8M | ---- |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | 100.66%12M | 73.15%-746M | 76.82%-1.82B | 88.50%-2.78B | -384.87%-7.83B | -80,613.33%-24.15B |
Sale of fixed assets | 1,216.67%158M | -97.69%12M | 16.05%629M | 305.47%519M | -4.07%542M | -75.29%128M | 25.56%565M | --518M | 196.05%450M | ---- |
Purchase of fixed assets | 95.66%-24M | 7.68%-553M | 54.32%-1.43B | 48.76%-599M | -4.27%-3.13B | 3.87%-1.17B | -11.33%-3B | 29.43%-1.22B | 16.63%-2.69B | 15.25%-1.72B |
Purchase of intangible assets | ---- | -22.26%-346M | -10.23%-517M | -29.22%-283M | 56.17%-469M | 35.40%-219M | 24.06%-1.07B | 81.78%-339M | -229.98%-1.41B | -439.42%-1.86B |
Sale of subsidiaries | -79.66%253M | 17,671.43%1.24B | 257.26%791M | -98.95%7M | 87.65%-503M | 130.89%667M | 38.29%-4.07B | 61.49%-2.16B | -1,373.21%-6.6B | -257.36%-5.61B |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---440M |
Recovery of cash from investments | 35.64%978M | -84.75%721M | -57.96%5.31B | 11.59%4.73B | -33.86%12.62B | -48.24%4.24B | -28.27%19.08B | -30.61%8.19B | 6.75%26.6B | -51.88%11.8B |
Cash on investment | 88.16%-54M | 79.08%-456M | 83.47%-5.37B | 84.95%-2.18B | -36.56%-32.47B | 5.22%-14.49B | 18.05%-23.77B | 12.21%-15.28B | 1.22%-29.01B | 18.09%-17.41B |
Other items in the investment business | -85.72%734M | 572.77%5.14B | 0.37%3.22B | -79.94%764M | -21.09%3.21B | 29.04%3.81B | 518.52%4.07B | --2.95B | 85.36%-972M | ---- |
Net cash from investment operations | -63.83%2.43B | 73.68%6.72B | 124.42%4.41B | 160.21%3.87B | -204.92%-18.04B | 18.35%-6.43B | 69.01%-5.92B | 79.22%-7.87B | -55.60%-19.09B | -443.51%-37.89B |
Net cash before financing | -77.77%2.25B | 10.80%10.11B | 656.94%40.03B | 130.99%9.12B | 73.91%-7.19B | 116.50%3.95B | -522.55%-27.55B | 33.63%-23.95B | -125.86%-4.43B | -848.48%-36.08B |
Cash flow from financing activities | ||||||||||
New borrowing | -84.54%2.2B | -45.56%14.21B | -65.68%47.09B | -62.51%26.1B | -3.04%137.23B | 17.62%69.62B | 26.32%141.53B | 37.90%59.19B | 2.87%112.05B | -45.43%42.92B |
Refund | 88.93%-4.1B | 36.16%-37.01B | 25.29%-107.86B | 23.10%-57.97B | 22.84%-144.38B | 26.55%-75.39B | -100.05%-187.1B | -161.33%-102.64B | -117.38%-93.53B | -36.36%-39.28B |
Issuing shares | ---- | ---- | --10.21B | ---- | ---- | ---- | ---- | ---- | -97.87%135M | -97.87%135M |
Issuance of bonds | -87.20%242M | 152.47%1.89B | -70.02%7.58B | -95.71%749M | -39.31%25.29B | 6.93%17.45B | 19.65%41.67B | -22.82%16.32B | -15.84%34.82B | 9.41%21.14B |
Dividends paid - financing | 83.33%-558M | -284.83%-3.35B | 58.76%-2.5B | 46.69%-870M | 62.53%-6.05B | -648.62%-1.63B | -55.16%-16.15B | -11.22%-218M | 16.83%-10.41B | 93.65%-196M |
Absorb investment income | ---- | -94.89%283M | -2.22%6.21B | 16.41%5.54B | 78.38%6.35B | 347.60%4.76B | 152.02%3.56B | -24.72%1.06B | -77.34%1.41B | -30.34%1.41B |
Issuance expenses and redemption of securities expenses | ---- | 33.84%-3.78B | 51.03%-15.46B | 35.75%-5.71B | -171.09%-31.57B | -42.55%-8.89B | -17.46%-11.65B | 20.79%-6.23B | 41.88%-9.91B | -41.58%-7.87B |
Other items of the financing business | 96.08%-374M | -2,347.44%-9.55B | -1,115.97%-3.88B | 95.63%-390M | 101.48%382M | -143.22%-8.92B | -184.33%-25.76B | -63.49%-3.67B | 44.92%-9.06B | 61.47%-2.24B |
Net cash from financing operations | 92.85%-2.67B | -14.55%-37.35B | -354.80%-58.69B | -951.13%-32.61B | 76.16%-12.9B | 91.47%-3.1B | -314.34%-54.14B | -327.19%-36.35B | -65.79%25.26B | -74.63%16B |
Effect of rate | -112.16%-9M | 572.73%74M | 88.89%-12M | 113.75%11M | 27.03%-108M | -186.02%-80M | 22.11%-148M | 60.34%93M | -160.32%-190M | -14.71%58M |
Net Cash | 98.45%-423M | -16.00%-27.24B | 7.12%-18.66B | -2,869.10%-23.48B | 75.40%-20.09B | 101.41%848M | -492.11%-81.68B | -200.31%-60.3B | -77.09%20.83B | -133.87%-20.08B |
Begining period cash | -94.44%7.13B | -12.71%128.28B | -12.08%146.95B | -12.08%146.95B | -32.87%167.15B | -32.87%167.15B | 9.04%248.99B | 9.04%248.99B | 66.57%228.34B | 66.57%228.34B |
Cash at the end | -93.38%6.7B | -18.11%101.12B | -12.71%128.28B | -26.46%123.48B | -12.08%146.95B | -11.05%167.92B | -32.87%167.15B | -9.38%188.78B | 9.04%248.99B | 6.06%208.32B |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- |
Auditor | -- | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- | PricewaterhouseCoopers | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.